Excessive dosage of pancreatic enzymes in cystic fibrosis (CF) patient
s can be associated with irreversible colonic stricture. Predisposing
factors include a young age group, previous intestinal surgery, and pr
olonged administration of high-dose lipase products. Prestricture symp
toms include abdominal pain, diarrhea, and hematochezia. Pathological
signs are ischemic denudation of the epithelium with reepithelializati
on, mild chronic inflammation, and extensive collagen synthesis with m
ural fibrosis. The lesion is distinct from Crohn's disease. Its pathop
hysiological mechanisms remain unknown.